Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

The diagnosis and treatment of invasive breast cancer requires a collaborative effort among
multiple subspecialties. Diagnostic imaging workup and biopsy play a key role in …

PURPOSE To provide recommendations on the best strategies for the management and on
the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with …

Purpose Placing clips in nodes with biopsy-confirmed metastasis before initiating
neoadjuvant therapy allows for evaluation of response in breast cancer. Our goal was to …

Importance Sentinel lymph node (SLN) surgery provides reliable nodal staging information
with less morbidity than axillary lymph node dissection (ALND) for patients with clinically …

Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer
patients with lymph node metastasis should receive after neoadjuvant chemotherapy. For …

Importance The increasing use of neoadjuvant chemotherapy (NAC) for operable breast
cancer has raised questions about optimal local therapy for the axilla. Observations Sentinel …

Background Bevacizumab and the antimetabolites capecitabine and gemcitabine have
been shown to improve outcomes when added to taxanes in patients with metastatic breast …

Purpose The American College of Surgeons Oncology Group Z1071 trial reported a 12.6%
false-negative rate (FNR) for sentinel lymph node (SLN) surgery after neoadjuvant …

PURPOSE Neoadjuvant systemic treatment (NST) elicits a pathologic complete response in
40%-70% of women with breast cancer. These patients may not need surgery as all local …